Co-Production of KPC-2 and NDM-5 in a Carbapenem-Resistant Klebsiella Pneumoniae Clinical Isolate: Genetic Insights and Risks.

IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2025-07-05 eCollection Date: 2025-01-01 DOI:10.2147/IDR.S523271
Yuanzhi Xia, Peiyao Zhou, Haojin Gao, Xiaocui Wu, Ying Zhou, Weihua Han, Cailing Wan, Qiong Wu, Jiawei Ding, Fangyou Yu
{"title":"Co-Production of KPC-2 and NDM-5 in a Carbapenem-Resistant <i>Klebsiella Pneumoniae</i> Clinical Isolate: Genetic Insights and Risks.","authors":"Yuanzhi Xia, Peiyao Zhou, Haojin Gao, Xiaocui Wu, Ying Zhou, Weihua Han, Cailing Wan, Qiong Wu, Jiawei Ding, Fangyou Yu","doi":"10.2147/IDR.S523271","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong> Carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP), particularly strains co-producing KPC and NDM carbapenemases, poses a severe global health threat due to limited treatment options. Understanding the genetic drivers of resistance and transmission is critical.</p><p><strong>Methods: </strong> A multidrug-resistant CRKP strain, KP3T58, co-harboring <i>bla<sub>KPC-2</sub></i>  and <i>bla<sub>NDM-5</sub></i> , was isolated from an ICU patient. Whole-genome sequencing and comparative genomic analyses were performed. Plasmid transferability was assessed via conjugation assays using <i>E. coli</i> EC600 as the recipient. Virulence phenotypes were evaluated through siderophore production (CAS assay), capsule quantification (uronic acid), serum resistance, and Galleria mellonella infection models. Antimicrobial susceptibility was determined (Vitek-2; CLSI/EUCAST standards).</p><p><strong>Results: </strong> KP3T58 exhibited resistance to nearly all antibiotics except polymyxin. The strain's multidrug-resistant (MDR) phenotype resulted from a combination of chromosomal mutations and the multiple plasmid-borne resistance genes. Whole-genome analysis identified three key plasmids: a conjugative plasmid pKP3T58_1 (IncFIB/FII/R type, carrying a large resistance gene cluster); a conjugative plasmid pKP3T58_2 (IncI1-I type, high-frequency transfer, carrying <i>bla<sub>NDM-5</sub></i> ); and a non-conjugative plasmid pKP3T58_3 (IncFII type, carrying <i>bla<sub>KPC-2</sub></i> ). Conjugation assays confirmed that pKP3T58_1 and pKP3T58_2 could transfer individually or jointly to <i>E. coli</i> EC600, while pKP3T58_3 (retaining only a partial T4SS) could co-transfer to recipient cells with the assistance of pKP3T58_2. MLST confirmed clonal persistence of the high-risk ST11 lineage within the patient. Phylogenetic analysis revealed KP3T58's clustering within a dominant epidemic ST11-KL64 subclade prevalent in China. Multiple virulence assays (including siderophore production, capsule quantification, serum resistance, and <i>Galleria mellonella</i> infection models) demonstrated that KP3T58 lacks a typical hypervirulent phenotype but retains a certain level of pathogenicity.</p><p><strong>Conclusion: </strong> This study demonstrates clonal evolution of ST11 CRKP to co-produce KPC-2 and NDM-5 within a host, clustering within a prevalent epidemic lineage. Critically, we provide experimental evidence that mobilizable plasmids retaining only a partial T4SS can undergo horizontal transfer when assisted by conjugative plasmids, fundamentally expanding our understanding of resistance dissemination. The convergence of high-risk epidemiology, MDR, and novel plasmid transfer mechanisms in strains like KP3T58 necessitates enhanced surveillance and urgent molecular investigation into the transmission dynamics of these threats.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"3329-3341"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239901/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S523271","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background:  Carbapenem-resistant Klebsiella pneumoniae (CRKP), particularly strains co-producing KPC and NDM carbapenemases, poses a severe global health threat due to limited treatment options. Understanding the genetic drivers of resistance and transmission is critical.

Methods:  A multidrug-resistant CRKP strain, KP3T58, co-harboring blaKPC-2  and blaNDM-5 , was isolated from an ICU patient. Whole-genome sequencing and comparative genomic analyses were performed. Plasmid transferability was assessed via conjugation assays using E. coli EC600 as the recipient. Virulence phenotypes were evaluated through siderophore production (CAS assay), capsule quantification (uronic acid), serum resistance, and Galleria mellonella infection models. Antimicrobial susceptibility was determined (Vitek-2; CLSI/EUCAST standards).

Results:  KP3T58 exhibited resistance to nearly all antibiotics except polymyxin. The strain's multidrug-resistant (MDR) phenotype resulted from a combination of chromosomal mutations and the multiple plasmid-borne resistance genes. Whole-genome analysis identified three key plasmids: a conjugative plasmid pKP3T58_1 (IncFIB/FII/R type, carrying a large resistance gene cluster); a conjugative plasmid pKP3T58_2 (IncI1-I type, high-frequency transfer, carrying blaNDM-5 ); and a non-conjugative plasmid pKP3T58_3 (IncFII type, carrying blaKPC-2 ). Conjugation assays confirmed that pKP3T58_1 and pKP3T58_2 could transfer individually or jointly to E. coli EC600, while pKP3T58_3 (retaining only a partial T4SS) could co-transfer to recipient cells with the assistance of pKP3T58_2. MLST confirmed clonal persistence of the high-risk ST11 lineage within the patient. Phylogenetic analysis revealed KP3T58's clustering within a dominant epidemic ST11-KL64 subclade prevalent in China. Multiple virulence assays (including siderophore production, capsule quantification, serum resistance, and Galleria mellonella infection models) demonstrated that KP3T58 lacks a typical hypervirulent phenotype but retains a certain level of pathogenicity.

Conclusion:  This study demonstrates clonal evolution of ST11 CRKP to co-produce KPC-2 and NDM-5 within a host, clustering within a prevalent epidemic lineage. Critically, we provide experimental evidence that mobilizable plasmids retaining only a partial T4SS can undergo horizontal transfer when assisted by conjugative plasmids, fundamentally expanding our understanding of resistance dissemination. The convergence of high-risk epidemiology, MDR, and novel plasmid transfer mechanisms in strains like KP3T58 necessitates enhanced surveillance and urgent molecular investigation into the transmission dynamics of these threats.

耐碳青霉烯肺炎克雷伯菌临床分离株中KPC-2和NDM-5的联合产生:遗传见解和风险
背景:耐碳青霉烯肺炎克雷伯菌(CRKP),特别是共同产生KPC和NDM碳青霉烯酶的菌株,由于治疗选择有限,对全球健康构成严重威胁。了解耐药性和传播的遗传驱动因素至关重要。方法:从1例ICU患者身上分离到一株共携带blaKPC-2和blaNDM-5的多重耐药CRKP菌株KP3T58。进行全基因组测序和比较基因组分析。以大肠杆菌EC600为受体,通过偶联试验评估质粒的可转移性。毒力表型通过铁载体产生(CAS测定)、胶囊定量(醛酸)、血清耐药性和mellonella感染模型进行评估。测定药物敏感性(Vitek-2;CLSI / EUCAST标准)。结果:KP3T58对除多粘菌素外的几乎所有抗生素均耐药。该菌株的多重耐药表型是由染色体突变和多重质粒耐药基因共同作用的结果。全基因组分析鉴定出三个关键质粒:一个共轭质粒pKP3T58_1 (IncFIB/FII/R型,携带大量抗性基因簇);接合质粒pKP3T58_2 (IncI1-I型,高频转移,携带blaNDM-5);非共轭质粒pKP3T58_3 (IncFII型,携带blaKPC-2)。偶联实验证实,pKP3T58_1和pKP3T58_2可以单独或联合转移到大肠杆菌EC600上,而pKP3T58_3在pKP3T58_2的帮助下可以共同转移到受体细胞上(pKP3T58_2只保留部分T4SS)。MLST证实了高危ST11谱系在患者体内的克隆持久性。系统发育分析显示,KP3T58属于中国流行的ST11-KL64亚支。多项毒力测定(包括铁载体产生、胶囊定量、血清耐药性和mellonia感染模型)表明,KP3T58缺乏典型的高毒力表型,但仍保持一定水平的致病性。结论:该研究证实了ST11 CRKP在宿主体内克隆进化,共同产生KPC-2和NDM-5,聚集在一个流行的流行病谱系中。重要的是,我们提供的实验证据表明,在共轭质粒的帮助下,只保留部分T4SS的可移动质粒可以进行水平转移,从根本上扩展了我们对耐药性传播的理解。在KP3T58等菌株中,高风险流行病学、耐多药和新型质粒转移机制的融合需要加强对这些威胁的传播动力学的监测和紧急分子调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信